Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors

Maschauer S, Einsiedel J, Reich D, Hübner H, Gmeiner P, Wester HJ, Prante O, Notni J (2017)

Publication Type: Journal article, Original article

Publication year: 2017

Journal

Pharmaceuticals MDPI

Book Volume: 10

Pages Range: 29

Journal Issue: 1

DOI: 10.3390/ph10010029

Abstract

Neurotensin receptor 1 (NTS1) is overexpressed on a variety of cancer entities; for example, prostate cancer, ductal pancreatic adenocarcinoma, and breast cancer. Therefore, it represents an interesting target for the diagnosis of these cancers types by positron emission tomography (PET) [...].

Authors with CRIS profile

Simone Maschauer Department of Nuclear Medicine Jürgen Einsiedel Lehrstuhl für Pharmazeutische Chemie Harald Hübner Lehrstuhl für Pharmazeutische Chemie Peter Gmeiner Lehrstuhl für Pharmazeutische Chemie Olaf Prante Professur für Molekulare Bildgebung und Radiochemie

Additional Organisation(s)

Emil-Fischer-Zentrum (Emil Fischer Center)

Involved external institutions

Technische Universität München (TUM) DE Germany (DE)

How to cite

APA:

Maschauer, S., Einsiedel, J., Reich, D., Hübner, H., Gmeiner, P., Wester, H.J.,... Notni, J. (2017). Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors. Pharmaceuticals, 10(1), 29. https://dx.doi.org/10.3390/ph10010029

MLA:

Maschauer, Simone, et al. "Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors." Pharmaceuticals 10.1 (2017): 29.

BibTeX: Download